Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

for
Lymphoma, Lymphoma, Non Hodgkin
Location: Nashville TN, St Louis MO, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07082803

Phase 1, Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

for
Esophageal Squamous Cell Carcinoma
Location: Nashville TN, Memphis TN, Detroit MI, Kansas City MO,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644781

Phase 3, Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

for
Extensive-Stage Small Cell Lung Cancer
Location: Nashville TN, Marietta GA, Cincinnati OH, Daphne AL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06646276

Phase 3, Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Nashville TN, Huntsville AL, Evansville IN,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

for
Multiple Myeloma, Newly Diagnosed, Multiple Myeloma (MM)
Location: Nashville TN, Birmingham AL, Columbus OH,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 19+

Code: NCT06974786

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Nashville TN, Fairfield OH, St Louis MO, Little Rock AR,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566156

Phase 3, Recruiting

Neoadjuvant Darovasertib in Primary Uveal Melanoma

for
Uveal Melanoma
Location: Nashville TN, Jacksonville FL, Grand Rapids MI,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07015190

Phase 3, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: Nashville TN, St Louis MO, Hattiesburg MS, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase 3, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Nashville TN, Birmingham AL, Atlanta GA, St Louis MO,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase 2, Recruiting

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

for
Follicular Lymphoma
Location: Nashville TN, Lexington KY, Durham NC, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07634471

Phase 2, Phase 3, Recruiting

INHANCE Stemless Reverse Shoulder IDE

for
Arthroplasty, Replacement, Shoulder
Location: Columbia TN, Cincinnati OH, Charlotte NC, Columbia MO,
Sponsor: DePuy Orthopaedics

Sex: All

Age: 22+

Code: NCT06323980

Recruiting

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

for
HER2 Expressing Solid Tumors
Location: Nashville TN, Cleveland OH, Jacksonville FL,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT07192432

Phase 1, Phase 2, Recruiting

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

for
AML, Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Location: Nashville TN, Houston TX, Denver CO, Sacramento CA,
Sponsor: CERo Therapeutics Holdings, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06834282

Phase 1, Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Nashville TN, Conroe TX, Toronto, League City TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07090499

Phase 1, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Nashville TN, Louisville KY, Newnan GA, Cincinnati OH,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase 3, Recruiting

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

for
B-cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Nashville TN, Macon GA, Indianapolis IN, Fort Wayne IN,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07516093

Phase 3, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: Nashville TN, Birmingham AL, Atlanta GA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase 3, Recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

for
Liposarcoma, Prostate Cancer, Advanced Breast Cancer,
Location: Nashville TN, Grand Rapids MI, Houston TX, Trumbull CT,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT04557449

Phase 1, Phase 2, Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Nashville TN, Louisville KY, Atlanta GA, Cincinnati OH,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase 3, Recruiting